Star Health Insurance & Allied Insurance Company Limited will host an in-person meeting with analysts and institutional investors on August 17, 2026, at the Motilal Oswal 22nd Annual Global Investor Conference in Mumbai. The event is scheduled to commence at 10:00 AM IST, providing stakeholders with a direct channel to discuss the insurer’s strategic outlook and operational performance for the upcoming fiscal year. This engagement aims to enhance transparency and align investor expectations with the company’s growth trajectory in the health insurance sector.

The disclosure was made in compliance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice was submitted to the Listing Departments of both BSE Limited and the National Stock Exchange of India Limited on August 7, 2026. Jayashree Sethuraman, Company Secretary & Compliance Officer, digitally signed the intimation, confirming the schedule’s validity subject to exigencies on the part of the analysts or investors.

Meeting Details

The interaction will take place in person, allowing for direct dialogue between company management and market participants. The presentation materials for the meeting have been made available online for pre-reading by interested parties.

Access to Presentation

Investors can access the presentation deck via the link provided in the regulatory filing. The document is also hosted on the company’s official website, www.starhealth.in , ensuring broad accessibility for all shareholders and market observers. The company noted that the schedule remains subject to change due to unforeseen circumstances involving the analysts or investors.

Regulatory Compliance

The intimation references Regulation 30 of the SEBI (LODR) Regulations, 2015, which mandates timely disclosure of material events and interactions with analysts. By proactively scheduling this meet, Star Health & Allied Insurance Company Limited adheres to best practices in corporate governance and investor relations. The filing ensures that both stock exchanges are formally notified, maintaining parity in information dissemination across all market participants.

Star Health & Allied Insurance Company company name will host analysts and institutional investors on August 14, 2026, during the Emkay Confluence 2026 event in Mumbai. The in-person meeting is scheduled to begin at 10:00 AM IST, providing market participants with a direct channel to discuss the insurer’s strategic outlook and operational performance for FY27. This engagement follows standard disclosure practices under SEBI regulations, ensuring transparency regarding the company’s upcoming fiscal year trajectory.

The announcement was made on August 07, 2026, via intimation letters submitted to the Listing Departments of both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE). The disclosure complies with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Jayashree Sethuraman, Company Secretary and Compliance Officer, signed off on the filing, confirming the schedule and regulatory adherence.

Meeting Details

The interaction will take place in Mumbai as part of the broader Emkay Confluence 2026 conference. Unlike virtual sessions, this format allows for real-time dialogue between management and investment professionals. The company noted that the schedule remains subject to change due to exigencies on the part of analysts or investors.

Investors interested in reviewing the company’s perspective prior to or following the session can access the presentation deck via the link provided in the exchange filing. The document is also hosted on the company’s official website, www.starhealth.in , ensuring broad accessibility for stakeholders who may not attend the physical event.

Regulatory Context

Under SEBI’s LODR regulations, listed entities are required to disclose the schedule of meetings with analysts and institutional investors promptly. This ensures that no single group of investors receives preferential information ahead of others. By publishing the details on August 07, 2026, Star Health maintains compliance with these transparency norms while preparing for its FY27 reporting cycle.

No financial results, dividend declarations, or corporate actions were announced alongside this scheduling notice. The focus remains strictly on investor relations and market communication ahead of the new fiscal year.